Global Pharmaceuticals & Biotech Most Searched for companies on Simply Wall St (do not delete)

Atara Biotherapeutics

Market Cap: US$124.2m

Engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and the United Kingdom.

Celcuity

Market Cap: US$4.7b

A clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States.

Paradigm Biopharmaceuticals

Market Cap: AU$137.1m

Engages in the research and development of therapeutic products for human use in Australia.

Jiangsu Hengrui PharmaceuticalsLtd

Market Cap: CN¥403.9b

A pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally.

Aurobindo Pharma

Market Cap: ₹711.5b

A biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables.

SCHOTT Pharma KGaA

Market Cap: €2.2b

Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide.

Takeda Pharmaceutical

Market Cap: JP¥7.3t

Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.

Sai Life Sciences

Market Cap: ₹192.9b

Operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally.

Sandoz Group

Market Cap: CHF 24.9b

Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.

Atossa Therapeutics

Market Cap: US$91.0m

Operates as a clinical-stage biopharmaceutical company that develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States.

Ascendis Pharma

Market Cap: US$12.2b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.

Abeona Therapeutics

Market Cap: US$266.6m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

IN8bio

Market Cap: US$6.4m

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell product candidates for the treatment of cancer and autoimmune diseases.

Context Therapeutics

Market Cap: US$105.7m

A biopharmaceutical company, develops products for the treatment of solid tumors.

Cytek Biosciences

Market Cap: US$613.8m

A cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications.

Pacific Biosciences of California

Market Cap: US$567.6m

Designs, develops, and manufactures sequencing solution to resolve genetically complex problems.

Pelthos Therapeutics

Market Cap: US$70.0m

A bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens.

ProKidney

Market Cap: US$743.1m

A clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States.

Evommune

Market Cap: US$473.2m

Operates as a clinical-stage biotechnology company in the United States.

MindWalk Holdings

Market Cap: US$76.6m

Operates as a bio-native AI company.

Amphastar Pharmaceuticals

Market Cap: US$1.2b

A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.

Lite Strategy

Market Cap: US$49.7m

A clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer.

CEL-SCI

Market Cap: US$44.1m

A clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States.

Madrigal Pharmaceuticals

Market Cap: US$12.4b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

Halozyme Therapeutics

Market Cap: US$7.7b

A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.

Adaptive Biotechnologies

Market Cap: US$2.5b

A commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.

Capricor Therapeutics

Market Cap: US$1.4b

A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.

Avantor

Market Cap: US$7.5b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Tenaya Therapeutics

Market Cap: US$111.2m

A clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States.

GlaxoSmithKline Pakistan

Market Cap: PK₨122.7b

Operates as a biopharma company in Pakistan.

Cipla

Market Cap: ₹1.2t

Manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally.

Pyridam Farma

Market Cap: Rp5.6t

Engages in the development, production, and trading of pharmaceuticals primarily in Indonesia.

CORONA Remedies

Market Cap: ₹84.1b

A pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products.

May & Baker Nigeria

Market Cap: ₦30.7b

May & Baker Nigeria Plc, together with its subsidiaries, manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria.

Bachem Holding

Market Cap: CHF 4.3b

Provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.

CytomX Therapeutics

Market Cap: US$657.4m

Operates as an oncology-focused biopharmaceutical company that focuses on developing novel conditionally activated biologics localized to the tumor microenvironment.